Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis AgfiledCriticalNovartis Ag
Application grantedgrantedCritical
Publication of TW377353BpublicationCriticalpatent/TW377353B/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
2-Amino-6-anilino-purine derivatives of the formula (I) in which the symbols are as defined in claim 1, are described. These compounds inhibit p34cdc2/cyclin Bcdc13 kinase and can be used for treatment of hyperproliferative diseases, for example tumour diseases.
TW085112673A1995-11-011996-10-17Purine derivatives and process for their preparation
TW377353B
(en)
17betha-substituted 4-aza-5alpha-androstane-3-on derivatives, process for their production and for the production of medical preparations containing them